Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed)
This FOA invites applications for continuation of the Collaborative Islet Transplantation Registry (CITR).
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes – Biostatistics Research Center (U01 Clinical Trial Not Allowed)
This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to better understand youth-onset type 2 diabetes.
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes – Clinical Centers (U01 Clinical Trial Not Allowed)
The purpose of this FOA is to create a clinical consortium to recruit a cohort of early pubertal youth at risk for developing type 2 diabetes and study them through puberty.
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
This initiative will support innovative research to develop, test and evaluate multi-level/multi-component strategies (including models of health care) to effectively adapt and implement comprehensive clinical care for individuals with Type 2 diabetes mellitus from populations with health disparities concordant with recommended and evidence-based guidelines.
Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
The National Cancer Institute (NCI) invites research grant applicationsfor transdisciplinary studies that will enhance our knowledge of the dynamics and underlying mechanisms that link obesity, metabolic dysregulation and increased cancer risk as part of the Metabolic Dysregulation and Cancer Risk Program.
Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK
NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19).
NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). NIDDK is particularly interested in projects focusing on the direct action of the virus on kidney, gastrointestinal tract function, and the endocrine/metabolic system, and the collection of biosamples that will inform the understanding of renal, gastrointestinal, and endocrine/metabolic sequelae of viral infection. Pilot clinical studies (observational and interventional) that support the understanding or treatment of COVID-19-related diseases within the mission of the NIDDK are also of interest. NIDDK will only consider applications that propose projects that may lead to rapid translation and impact in the COVID-19 emergency to be responsive to this NOSI.
Please submit applications for this initiative using the following funding opportunity announcement (FOA) below:
PA-18-935: Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
The application due date is June 01, 2020.
More information about the COVID-19 NIDDK NOSI is available at: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-018.html.
Please direct all inquiries to the appropriate NIDDK staff contact below:
Ivonne H. Schulman
Division of Kidney, Urologic and Hematologic Diseases (DKUH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 385-5744
Email: ivonne.schulman@nih.gov
Christine Lee
Division of Diabetes, Endocrinology and Metabolic Diseases (DEM)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 594-8806
Email: christine.lee2@nih.gov
Peter Perrin
|Division of Digestive Diseases and Nutrition (DDN)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 451-3759
Diabetes Research Connection
The Diabetes Research Connection is a 501(c)(3) nonprofit organization headquartered in San Diego, California.
Our Vision: To support innovative scientific inquiry
until diabetes is eliminated.
The Diabetes Research Connection is a 501(c)(3) nonprofit organization headquartered in San Diego, California. Established in 2012 by five tireless proponents of diabetes research, our mission is to connect donors with early-career scientists enabling them to perform peer-reviewed, novel research designed to prevent and cure type 1 diabetes, minimize its complications and improve the quality of life for those living with the disease.
One out of every hundred Americans has type 1 diabetes. Millions of children and adults struggle with this autoimmune disease. Despite these numbers, funding for diabetes research has declined. Of the funding available, 97% goes to established scientists.
Scientific breakthroughs often emerge due to the inventiveness of early-career scientists. Albert Einstein revealed his theory of general relativity at 26. Banting & Best discovered insulin before they turned 33. Imagine our world today if these scientists had not received funding for their research? These young scientists have exciting new ideas however, mainstream funding rarely supports them, so their ideas simply can’t off the ground…until now.
We grant up to $50,000 to support each research project.
How it Works
Scientists from across the country submit their projects through our website. Members of our panel of more than 80 of the leading diabetes experts review each proposal for innovation, value and feasibility. These established scientists donate their time and expertise to encourage the next generation of diabetes investigators
The time from application to funding can be as few as 12 weeks, compared to over a year for other funding agencies. 100% of our research funds will go directly to the scientists. To ensure transparency, each researcher provides updates on their project and posts final outcomes on our website.
Support comes from tax-deductible donations made by individuals, corporations and foundations. Donors have the power to select the research project or projects they wish to fund from an array of peer-reviewed proposals posted on our website.
Ordinary people making extraordinary efforts is what changes the world. Your support may very well be what unlocks the diabetes puzzle that continues to plague millions of people.